Trillium Therapeutics (TSX:TRIL) stock is on the rise following the announcement that Pfizer plans to buy it. Pfizer stocks were also trading in the green territory in the premarket trading hours on Monday, up by over three per cent. Know more on Pfizer Trillium deal and if it's a good time to buy the Trillium stock.
Trillium stock is rising on Pfizer deal: Time to buy?
Follow us on
Google News:

Featured Articles

World news
Brazil senator says he attended election conspiracy meeting with Bolsonaro
- February 03, 2023 07:58 AM AEDT
- Reuters

Business Assets
Bank of Canada to auction C$3.5 billion of bonds due 2025
- February 02, 2023 03:48 PM EST
- Reuters

Business Assets
Bolivia's economy grew 4.28% y/y in Q3 2022 -minister
- February 03, 2023 07:45 AM AEDT
- Reuters


World news
Israel, Sudan announce deal to normalise relations
- February 03, 2023 07:29 AM AEDT
- Reuters